Lennart Tonneijck

20142019
If you made any changes in Pure these will be visible here soon.

Research Output 2014 2019

Filter
Article

Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial

Muskiet, M. H. A., Bunck, M. C., Heine, R. J., Cornér, A., Yki-Järvinen, H., Eliasson, B., Joles, J. A., Diamant, M., Tonneijck, L. & van Raalte, D. H., 2019, In : Diabetes Research and Clinical Practice. 153, p. 14-22

Research output: Contribution to journalArticleAcademicpeer-review

Renal sinus fat and renal hemodynamics: a cross-sectional analysis

Spit, K. A., Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Joles, J. A., de Boer, A. & van Raalte, D. H., 2019, In : Magnetic Resonance Materials in Physics, Biology and Medicine.

Research output: Contribution to journalArticleAcademicpeer-review

Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus

Tonneijck, L., Muskiet, M. H. A., Blijdorp, C. J., Smits, M. M., Twisk, J. W., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A., Hoorn, E. J. & van Raalte, D. H., 2019, In : American Journal of Physiology. Renal Physiology. 316, 2, p. F231-F240

Research output: Contribution to journalArticleAcademicpeer-review

2018

Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials

Tonneijck, L., Muskiet, M. H. A., Smits, M. M., Bjornstad, P., Kramer, M. H. H., Diamant, M., Hoorn, E. J., Joles, J. A. & van Raalte, D. H., 2018, In : Diabetes, Obesity and Metabolism. 20, 5, p. 1235-1245

Research output: Contribution to journalArticleAcademicpeer-review

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial

Muskiet, M. H. A., Tonneijck, L., Huang, Y., Liu, M., Saremi, A., Heerspink, H. J. L. & van Raalte, D. H., 2018, In : The Lancet Diabetes and Endocrinology. 6, 11, p. 859-869

Research output: Contribution to journalArticleAcademicpeer-review

Lixisenatide versus insulin glulisine on fasting and postbreakfast systemic hemodynamics in type 2 diabetes mellitus patients

Tonneijck, L., Muskiet, M. H. A., Twisk, J. W., Kramer, M. H. H., Jan Danser, A. H., Joles, J. A., Smits, M. M. & van Raalte, D. H., 2018, In : Hypertension. 72, 2, p. 314-322

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2017

Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Diamant, M., Kramer, M. H. H., Cahen, D. L. & van Raalte, D. H., Apr 2017, In : Diabetic Medicine. 34, 4, p. 591-592 2 p.

Research output: Contribution to journalArticleAcademicpeer-review

Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Pieters-van den Bos, I. C., Vendrik, K. E. W., Hoekstra, T., Bruno, M. J., Diamant, M., van Raalte, D. H. & Cahen, D. L., Mar 2017, In : Diabetes Care. 40, 3, p. 301-308 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2016

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Tonneijck, L., Smits, M. M., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A. & van Raalte, D. H., Jul 2016, In : Diabetologia. 59, 7, p. 1412-1421

Research output: Contribution to journalArticleAcademicpeer-review

Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men

Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M., Diamant, M., Joles, J. A. & van Raalte, D. H., Feb 2016, In : Diabetes, Obesity and Metabolism. 18, 2, p. 178-185

Research output: Contribution to journalArticleAcademicpeer-review

Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Nieuwdorp, M., Groen, A. K., Cahen, D. L. & van Raalte, D. H., Dec 2016, In : Diabetes, Obesity and Metabolism. 18, 12, p. 1217-1225

Research output: Contribution to journalArticleAcademicpeer-review

GLP-1 based therapies: clinical implications for gastroenterologists

Smits, M. M., van Raalte, D. H., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H. & Cahen, D. L., Apr 2016, In : Gut. 65, 4, p. 702-11 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Renoprotection in LEADER and EMPA-REG OUTCOME

Muskiet, M. H. A., Tonneijck, L., van Bommel, E. J. M., Smits, M. M. & van Raalte, D. H., 2016, In : Lancet diabetes & endocrinology. 4, 10, p. 812-4 3 p.

Research output: Contribution to journalArticleAcademicpeer-review

Virus-Specific CD8+ T Cells Cross-Reactive to Donor-Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected with CMV and/or EBV

Heutinck, K. M., Yong, S. L., Tonneijck, L., Van Den Heuvel, H., Van Der Weerd, N. C., Van Der Pant, K. A. M. I., Bemelman, F. J., Claas, F. H. J. & Ten Berge, I. J. M., 1 May 2016, In : American Journal of Transplantation. 16, 5, p. 1480-1491 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Incretin-based drugs and renoprotection-is hyperfiltration key?

Tonneijck, L., Smits, M. M., van Raalte, D. H. & Muskiet, M. H. A., 2015, In : Kidney International. 87, 3, p. 660-661

Research output: Contribution to journalArticleAcademicpeer-review

Pleiotropic effects of type 2 diabetes management strategies on renal risk factors

Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Heerspink, H. J. L. & van Raalte, D. H., 2015, In : Lancet diabetes & endocrinology. 3, 5, p. 367-381

Research output: Contribution to journalArticleAcademicpeer-review

Understanding Empa-Reg Outcome

Muskiet, M. H. A., van Raalte, D. H., van Bommel, E., Smits, M. M. & Tonneijck, L., 2015, In : Lancet diabetes & endocrinology. 3, 12, p. 928-929

Research output: Contribution to journalArticleAcademicpeer-review

2014

ACE-I vs. ARB for blood pressure control in diabetic kidney disease

Tonneijck, L., Muskiet, M. H. A. & van Raalte, D. H., 2014, In : Kidney International. 86, 6, p. 1270-1270

Research output: Contribution to journalArticleAcademicpeer-review

Combining incretin-based drugs and RAAS inhibitors: more cons than pros?

Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Raalte, D. H. & Diamant, M., 2014, In : Lancet diabetes & endocrinology. 2, 9, p. 684-685

Research output: Contribution to journalArticleAcademicpeer-review